Active Ingredient: CEFTOBIPROLE MEDOCARIL SODIUM
Proprietary Name: ZEVTERA
Dosage Form; Route of Administration: POWDER; INTRAVENOUS
Strength: 667MG/VIAL
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N218275
Product Number: 001
Approval Date: Apr 3, 2024
Applicant Holder Full Name: BASILEA PHARMACEUTICA INTERNATIONAL LTD ALLSCHWIL
Marketing Status:
Discontinued
Patent and Exclusivity Information
